{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:10:15Z","timestamp":1780564215364,"version":"3.54.1"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"National Institutes of Health Office of the Director","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.neurobiolaging.2026.04.005","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T22:19:55Z","timestamp":1776637195000},"page":"8-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Predicting future cognitive impairment in preclinical Alzheimer\u2019s disease using amyloid PET and MRI: A multisite machine learning study"],"prefix":"10.1016","volume":"165","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2558-4132","authenticated-orcid":false,"given":"Braden","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Earnest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Bilgel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn S.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sterling C.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Davatzikos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guray","family":"Erus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin L.","family":"Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Resnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael I.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammie L.S.","family":"Benzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristeidis","family":"Sotiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13195-022-01055-y","article-title":"Perspectives and challenges in patient stratification in Alzheimer\u2019s disease","volume":"14","author":"Abdelnour","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib2","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2174\/156720501108140910121920","article-title":"Cognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype","volume":"11","author":"Albert","year":"2014","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib3","first-page":"164","article-title":"Enrichment factors for clinical trials in mild-to-moderate Alzheimer\u2019s disease","volume":"5","author":"Ballard","year":"2019","journal-title":"Alzheimers Dement. Transl. Res. Clin. Inter."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2018.101645","article-title":"Automated classification of Alzheimer\u2019s disease and mild cognitive impairment using a single MRI and deep neural networks","volume":"21","author":"Basaia","year":"2019","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib5","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1093\/brain\/awx243","article-title":"Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer\u2019s disease","volume":"140","author":"Bejanin","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae445","article-title":"Deep learning-based patient stratification for prognostic enrichment of clinical dementia trials","volume":"6","author":"Birkenbihl","year":"2024","journal-title":"Brain Commun."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib7","unstructured":"Centers for Medicare & Medicaid Services, 2023. Beta amyloid positron emission tomography in dementia and neurodegenerative disease (CAG-00431R). Available at: https:\/\/www.cms.gov\/medicare-coverage-database\/view\/ncacal-decision-memo.aspx?proposed=N&ncaid=308."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/radadv\/umae019","article-title":"Deep learning-based amyloid PET harmonization to predict cognitive decline in non-demented elderly","volume":"1","author":"Choi","year":"2024","journal-title":"Radiol. Adv."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib9","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/0891988705281881","article-title":"Antecedent biomarkers of Alzheimer\u2019s disease: The Adult Children Study","volume":"18","author":"Coats","year":"2005","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.14283\/jpad.2023.30","article-title":"Lecanemab: appropriate use recommendations","volume":"10","author":"Cummings","year":"2023","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib11","first-page":"255","article-title":"Harvard Aging Brain Study: Dataset and accessibility","volume":"144","author":"Dagley","year":"2017","journal-title":"NeuroImage Data Shar. Part II"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13195-021-00886-5","article-title":"Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer\u2019s disease","volume":"13","author":"Dansson","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib13","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/pst.2285","article-title":"Natural cubic splines for the analysis of Alzheimer\u2019s clinical trials","volume":"22","author":"Donohue","year":"2023","journal-title":"Pharm. Stat."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib14","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaneurol.2014.803","article-title":"The Preclinical Alzheimer Cognitive Composite: measuring amyloid-related decline","volume":"71","author":"Donohue","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neuroimage.2015.11.073","article-title":"MUSE: MUlti-atlas region Segmentation utilizing Ensembles of registration algorithms and parameters, and locally optimal atlas selection","volume":"127","author":"Doshi","year":"2016","journal-title":"NeuroImage"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib17","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/alz.12491","article-title":"Predictive value of ATN biomarker profiles in estimating disease progression in Alzheimer\u2019s disease dementia","volume":"17","author":"Ezzati","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib18","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.231442","article-title":"AmyloidPETNet: Classification of amyloid positivity in brain PET imaging using end-to-end deep learning","volume":"311","author":"Fan","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib19","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/jamaneurol.2017.0892","article-title":"Association of longitudinal cognitive decline with amyloid burden in middle-aged and older adults: evidence for a dose-response relationship","volume":"74","author":"Farrell","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3233\/ADR-210005","article-title":"Fifteen years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: progress and pbservations from 2,359 older adults spanning the spectrum from cognitive normality to Alzheimer\u2019s disease","volume":"5","author":"Fowler","year":"2021","journal-title":"J. Alzheimers Dis. Rep."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib21","article-title":"Machine learning\u2013enhanced screening funnel for clinical trials in Alzheimer\u2019s disease","volume":"11","author":"Gladstein","year":"2025","journal-title":"Alzheimers Dement. Transl. Res. Clin. Inter."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib22","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jalz.2018.04.011","article-title":"PET staging of amyloidosis using striatum","volume":"14","author":"Hanseeuw","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neuroimage.2013.10.067","article-title":"On the interpretation of weight vectors of linear models in multivariate neuroimaging","volume":"87","author":"Haufe","year":"2014","journal-title":"NeuroImage"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12929-019-0609-7","article-title":"Clinical trials of new drugs for Alzheimer disease","volume":"27","author":"Huang","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib25","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","article-title":"Biomarker modeling of Alzheimer\u2019s disease","volume":"80","author":"Jack","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib26","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup","volume":"20","author":"Jack Jr","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib27","first-page":"130","article-title":"The Wisconsin Registry for Alzheimer\u2019s prevention: a review of findings and current directions","volume":"10","author":"Johnson","year":"2018","journal-title":"Alzheimers Dement. Diagn. Assess. Dis. Monit."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib28","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ana.24546","article-title":"Tau positron emission tomographic imaging in aging and early Alzheimer disease","volume":"79","author":"Johnson","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib29","doi-asserted-by":"crossref","first-page":"e2673","DOI":"10.1212\/WNL.0000000000012022","article-title":"Finding treatment effects in Alzheimer trials in the face of disease progression heterogeneity","volume":"96","author":"Jutten","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277322","article-title":"Machine learning based multi-modal prediction of future decline toward Alzheimer\u2019s disease: an empirical study","volume":"17","author":"Karaman","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3233\/JAD-215699","article-title":"Alzheimer\u2019s disease: key insights from two decades of clinical trial failures","volume":"87","author":"Kim","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","article-title":"The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET","volume":"11","author":"Klunk","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02252964","article-title":"Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer\u2019s disease: Correlation with memory functions","volume":"9","author":"Laakso","year":"1995","journal-title":"J. Neural Transm. - Park. Dis. Dement. Sect."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib34","article-title":"OASIS-3: longitudinal neuroimaging, clinical, and cognitive dataset for normal aging and Alzheimer disease","author":"LaMontagne","year":"2019","journal-title":"medRxiv 2019"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib35","doi-asserted-by":"crossref","first-page":"e1452","DOI":"10.1212\/WNL.0000000000005354","article-title":"Memory decline accompanies subthreshold amyloid accumulation","volume":"90","author":"Landau","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib36","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1007\/s00259-014-2753-3","article-title":"Amyloid PET imaging in Alzheimer\u2019s disease: a comparison of three radiotracers","volume":"41","author":"Landau","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14528","article-title":"Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer\u2019s disease","volume":"21","author":"Leuzy","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neuroimage.2016.02.044","article-title":"Control-group feature normalization for multivariate pattern analysis of structural MRI data using the support vector machine","volume":"132","author":"Linn","year":"2016","journal-title":"NeuroImage"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neurobiolaging.2017.06.027","article-title":"Identifying incipient dementia individuals using machine learning and amyloid imaging","volume":"59","author":"Mathotaarachchi","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib40","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jamaneurol.2019.2214","article-title":"Staging \u03b2-amyloid pathology with amyloid positron emission tomography","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib41","doi-asserted-by":"crossref","first-page":"e2933","DOI":"10.1212\/WNL.0000000000012108","article-title":"Comparing PET and MRI biomarkers predicting cognitive decline in preclinical Alzheimer disease","volume":"96","author":"Mayblyum","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib42","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.neuroimage.2008.10.031","article-title":"Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: Results from ADNI","volume":"44","author":"Misra","year":"2009","journal-title":"NeuroImage"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib43","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1017\/S1041610297004870","article-title":"Clinical Dementia Rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type","volume":"9","author":"Morris","year":"1997","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib44","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1212\/WNL.59.6.867","article-title":"Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease","volume":"59","author":"Mungas","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib45","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213490","article-title":"A machine learning approach to predict cognitive decline in Alzheimer disease clinical trials","volume":"104","author":"Nallapu","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib46","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1093\/brain\/awn146","article-title":"Ventricular enlargement as a possible measure of Alzheimer\u2019s disease progression validated using the Alzheimer\u2019s disease neuroimaging initiative database","volume":"131","author":"Nestor","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib47","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaneurol.2021.1858","article-title":"Accuracy of tau positron emission tomography as a prognostic marker in preclinical and prodromal Alzheimer disease: a head-to-head comparison against amyloid positron emission tomography and magnetic resonance imaging","volume":"78","author":"Ossenkoppele","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbas.2023.100074","article-title":"Longitudinal association between \u00df-amyloid accumulation and cognitive decline in cognitively healthy older adults: A systematic review","volume":"3","author":"Parent","year":"2023","journal-title":"Aging Brain"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib49","article-title":"Topographical distribution of A\u03b2 predicts progression to dementia in A\u03b2 positive mild cognitive impairment","volume":"12","author":"Pascoal","year":"2020","journal-title":"Alzheimers Dement. Diagn. Assess. Dis. Monit."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.neurobiolaging.2021.06.014","article-title":"Unique regional patterns of amyloid burden predict progression to prodromal and clinical stages of Alzheimer\u2019s disease","volume":"106","author":"Pfeil","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib51","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","article-title":"Tangles and plaques in nondemented aging and \u201cpreclinical\u201d Alzheimer\u2019s disease","volume":"45","author":"Price","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14338","article-title":"Updated appropriate use criteria for amyloid and tau PET: a report from the Alzheimer\u2019s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup","volume":"21","author":"Rabinovici","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib53","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s43587-023-00410-4","article-title":"Detection and treatment of Alzheimer\u2019s disease in its preclinical stage","volume":"3","author":"Rafii","year":"2023","journal-title":"Nat. Aging"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib54","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/alz.12748","article-title":"The AHEAD 3\u201345 study: design of a prevention trial for Alzheimer\u2019s disease","volume":"19","author":"Rafii","year":"2023","journal-title":"Alzheimers Dement. J. Alzheimers Assoc."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib55","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.neuroimage.2017.03.057","article-title":"A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer\u2019s disease and its prodromal stages","volume":"155","author":"Rathore","year":"2017","journal-title":"NeuroImage"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib56","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/cercor\/10.5.464","article-title":"One-year age changes in MRI brain volumes in older adults","volume":"10","author":"Resnick","year":"2000","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib57","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000115751","article-title":"The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics","volume":"30","author":"Roberts","year":"2008","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib58","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.neuroimage.2018.08.042","article-title":"Reproducible evaluation of classification methods in Alzheimer\u2019s disease: framework and application to MRI and PET data","volume":"183","author":"Samper-Gonz\u00e1lez","year":"2018","journal-title":"NeuroImage"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib59","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib60","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/archneurol.2011.559","article-title":"Prediction of cognitive decline by positron emission tomography of brain amyloid and tau","volume":"69","author":"Small","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib61","first-page":"S208","article-title":"Advances in functional and structural MR image analysis and implementation as FSL","volume":"23","author":"Smith","year":"2004","journal-title":"NeuroImage Math. Brain Imaging"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib62","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa2305032","article-title":"Trial of Solanezumab in preclinical Alzheimer\u2019s disease","volume":"389","author":"Sperling","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib63","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007941","article-title":"The A4 study: Stopping AD before symptoms begin?","volume":"6","author":"Sperling","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib64","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/1471-2105-9-307","article-title":"Conditional variable importance for random forests","volume":"9","author":"Strobl","year":"2008","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib65","first-page":"180","article-title":"Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies","volume":"11","author":"Su","year":"2019","journal-title":"Alzheimers Dement. Diagn. Assess. Dis. Monit."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib66","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13195-021-00813-8","article-title":"A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer\u2019s disease with lecanemab, an anti-A\u03b2 protofibril antibody","volume":"13","author":"Swanson","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib67","doi-asserted-by":"crossref","first-page":"400","DOI":"10.14283\/jpad.2022.49","article-title":"Prediction of cognitive decline for enrichment of Alzheimer\u2019s disease clinical trials","volume":"9","author":"Tam","year":"2022","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib68","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib69","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1109\/TMI.2010.2046908","article-title":"N4ITK: Improved N3 bias correction","volume":"29","author":"Tustison","year":"2010","journal-title":"IEEE Trans. Med. Imaging"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib70","doi-asserted-by":"crossref","first-page":"e662","DOI":"10.1212\/WNL.0000000000011222","article-title":"Association of \u03b2-Amyloid level, clinical progression, and longitudinal cognitive change in normal older individuals","volume":"96","author":"van der Kall","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib71","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00259-012-2088-x","article-title":"Comparison of 11C-PiB and 18F-florbetaben for A\u03b2 imaging in ageing and Alzheimer\u2019s disease","volume":"39","author":"Villemagne","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-024-02819-w","article-title":"A multimodal deep learning approach for the prediction of cognitive decline and its effectiveness in clinical trials for Alzheimer\u2019s disease","volume":"14","author":"Wang","year":"2024","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib73","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1212\/WNL.0000000000003126","article-title":"Enrichment of clinical trials in MCI due to AD using markers of amyloid and neurodegeneration","volume":"87","author":"Wolz","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.04.005_bib74","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba4373","article-title":"Toward robust mammography-based models for breast cancer risk","volume":"13","author":"Yala","year":"2021","journal-title":"Sci. Transl. Med."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019745802600062X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019745802600062X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:52:13Z","timestamp":1780563133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019745802600062X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":74,"alternative-id":["S019745802600062X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2026.04.005","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting future cognitive impairment in preclinical Alzheimer\u2019s disease using amyloid PET and MRI: A multisite machine learning study","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2026.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}